5:01 Acquisition Corp.

Status: Liquidated
U=S
IPO Proceeds, $M $82.56M
IPO Date Oct 14, 2020
CEO Andrew J. Schwab; Kush M. Parmar, M.D., Ph.D.
Left Lead BofA Securities
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Biotechnology in North America and Europe

IPO Geography US/Canada
Target Company N/A
Deal Announced N/A
Deal Size, $M TBD
Deal Sector TBD
Deal Geography TBD
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote TBD
Closing Date Oct 17, 2022
FVAM

Sign up for Free Trial

No credit card required

Sign in for more on 5:01 Acquisition Corp.:

  • Structure and cap table
  • 7 directors & officers
  • 8 filings and events
  • 1 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Andrew J. Schwab 49 Co-CEO and Director
Kush M. Parmar, M.D., Ph.D. 39 Co-CEO and Director
Galya D. Blachman, Ph.D., Esq. 43 General counsel and secretary
Rebecca L. Lucia 48 CFO and Treasurer
Jason R. Ruth, Ph.D. 35 Chief Business Officer
Daniella Beckman 42 Director
Matthew Patterson 49 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
BofA Securities BR 8,000,000 units
8,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee
3.50 %

Sign in to view more advisor data.

Filings
Sep 25, 2020 Initial S-1
Oct 8, 2020

Sign In to view filing content.

Oct 13, 2020

Sign In to view filing content.

Oct 14, 2020 424B4 IPO Prospectus
Nov 18, 2020

Sign In to view filing content.

Oct 29, 2021

Sign In to view filing content.

Apr 25, 2022

Sign In to view filing content.

Sep 20, 2022

Sign In to view filing content.

Shareholders

Sign in to view shareholders 13F filing data.